Literature DB >> 20543822

Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma.

Chan-Kwon Jung1, Yoon-Goo Kang, Ja-Seong Bae, Dong-Jun Lim, Yeong-Jin Choi, Kyo-Young Lee.   

Abstract

Although many attempts have been made to predict the occurrence of lymph node metastases from papillary thyroid carcinoma, there are currently no reliable means to accurately predict cervical nodal metastasis. In this study, we present a novel prediction system for the lymph node metastasis based on the histological and cyclin D1 staining features. The frequency of lymph node metastases from a series of 210 papillary thyroid carcinomas was analyzed according to the clinicopathological variables, cyclin D1 staining patterns and BRAF(V600E) mutation in tumor tissue. A total of 113 (54%) patients had lymph node metastasis. Cyclin D1 was constantly expressed at the invasive tumor front and revealed well-defined isolated glands of tumor cells in the extra-tumoral region (isolated glands) and laterally spreading tubular growth along the fibrous septa around the invasive front of the tumor (lateral tubular growth). Upon univariate analysis, an age of less than 45 years (P<0.001), tumor size of 10 mm or more (P<0.001), non-follicular variant (P=0.005), invasive growth pattern (P=0.007), extrathyroid extension (P=0.006), isolated glands (P<0.001), lateral tubular growth (P<0.001) and tumor multiplicity (P=0.005) predicted lymph node metastasis, whereas BRAF(V600E) mutation did not. Upon multivariate analysis, age (P=0.001, odds ratio (OR)=5.146), tumor size (P=0.034, OR=3.119), isolated glands (P<0.001, OR=21.042) and lateral tubular growth (P<0.001, OR=24.652) were found to be strong independent predictors of lymph node metastasis. Cyclin D1 staining of papillary thyroid carcinoma is very useful for identifying the intrathyroidal spreading or multifocality of the tumors. Tumor growth patterns verified by cyclin D1 staining can be used for the identification of papillary thyroid carcinomas with metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543822     DOI: 10.1038/modpathol.2010.116

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.

Authors:  Jun-Mei Xu; Xiao-Hong Xu; Hui-Xiong Xu; Yi-Feng Zhang; Le-Hang Guo; Lin-Na Liu; Chang Liu; Xiao-Wan Bo; Shen Qu; Mingzhao Xing; Xiao-Long Li
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

2.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.

Authors:  Julio Ricarte-Filho; Ian Ganly; Michael Rivera; Nora Katabi; Weimin Fu; Ashok Shaha; R Michael Tuttle; James A Fagin; Ronald Ghossein
Journal:  Thyroid       Date:  2012-04-03       Impact factor: 6.568

Review 3.  The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Liang-Sen Liu; Jia Liang; Jun-Hong Li; Xue Liu; Li Jiang; Jian-Xiong Long; Yue-Ming Jiang; Zhi-Xiao Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-19       Impact factor: 2.503

4.  BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.

Authors:  Carol Li; Kathleen C Lee; Eric B Schneider; Martha A Zeiger
Journal:  J Clin Endocrinol Metab       Date:  2012-10-09       Impact factor: 5.958

Review 5.  The association between BRAF (V600E) mutation and pathological features in PTC.

Authors:  Xin Liu; Kangkang Yan; Xuejun Lin; Longyu Zhao; Wenxiu An; Chunpeng Wang; Xiaodong Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-04       Impact factor: 2.503

6.  BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Fei Li; Guangqi Chen; Chunjun Sheng; Aaron M Gusdon; Yueye Huang; Zhongwei Lv; Huixiong Xu; Mingzhao Xing; Shen Qu
Journal:  Endocr Relat Cancer       Date:  2015-01-15       Impact factor: 5.678

7.  TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; J Cameselle-Teijeiro; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2012-04-20       Impact factor: 4.064

8.  Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading.

Authors:  Orhun Cig Taskin; Michelle D Reid; Pelin Bagci; Serdar Balci; Ayse Armutlu; Deniz Demirtas; Burcin Pehlivanoglu; Burcu Saka; Bahar Memis; Emine Bozkurtlar; Can Berk Leblebici; Adelina Birceanu; Yue Xue; Mert Erkan; Yersu Kapran; Arzu Baygul; Cenk Sokmensuer; Aldo Scarpa; Claudio Luchini; Olca Basturk; Volkan Adsay
Journal:  Mod Pathol       Date:  2021-12-30       Impact factor: 7.842

9.  BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.

Authors:  Yu-Jia Ma; Xiu-Ling Deng; Hui-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

10.  Ultrasound Echogenicity of Papillary Thyroid Cancer Is Affected by Tumor Growth Patterns and Tumor Fibrosis.

Authors:  Yun-Sung Lim; Yoon Se Lee; Jin-Choon Lee; Seok-Man Son; Dong-Hoon Shin; Sang Soo Kim; In-Ju Kim; Byung-Joo Lee
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.